Clobazam Synthesis via One-Pot Condensation and Cyclization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for the synthesis of Clobazam and its intermediates suffer from low yield, critical reaction conditions, use of costly and toxic solvents, and complex purification steps, making them industrially unfeasible and costly.
Innovation Solution
A novel process involving the reaction of compound (II) with monoalkyl malonate in the presence of a coupling agent, followed by cyclization with a base, and subsequent methylation with a methylating agent in the absence of a phase transfer catalyst, simplifies the synthesis and eliminates the need for expensive solvents and additional purification steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing processes for synthesis of Clobazam and its intermediates are used, then the synthesis can be performed, but the yield is low and the process is costly
Solution Approach 1:
The patent changes the reaction parameters by using a one-pot two-step methodology that combines condensation and cyclization in a single reaction vessel. This approach modifies the reaction conditions to achieve higher yields of compound (IV) while reducing the number of isolation and purification steps, thereby lowering manufacturing costs and improving overall productivity.
2Productivity
If existing processes are used, then the synthesis can be performed, but critical reaction conditions and complex purification steps are required
Solution Approach 1:
The patent merges the condensation reaction and cyclization reaction into a single one-pot two-step process. This consolidation eliminates the need for separate purification steps between reactions, reducing process complexity while maintaining high synthesis efficiency. The intermediate product is directly converted to the final product without isolation, simplifying the overall manufacturing workflow.
3Productivity
If existing processes are used, then the synthesis can be performed, but costly and toxic solvents are required
Solution Approach 1:
The patent employs water as the reaction medium instead of costly and toxic organic solvents. Water is inexpensive, non-toxic, and environmentally friendly. The reaction proceeds efficiently in aqueous medium, eliminating the need for expensive solvent recovery and disposal processes, thereby reducing both cost and environmental impact while maintaining reaction efficiency.
4Productivity
If phase transfer catalyst is used in methylation, then the reaction can proceed, but additional purification steps and expensive reagents are needed
Solution Approach 1:
The patent removes the phase transfer catalyst from the methylation process by using dimethyl carbonate as the methylating agent. This extraction of the problematic catalyst eliminates the need for additional purification steps to remove catalyst residues, simplifying the manufacturing process and reducing costs while maintaining methylation efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves improved yield and purity of Clobazam and its intermediates, reducing overall costs and making the synthesis commercially scalable and environmentally friendly.
Implementation Method 1
reacting the compound (II) with monoalkyl malonate in the presence of a coupling agent to obtain the compound (III)
Implementation Method 2
followed by the cyclization using a base
Implementation Method 3
reacting the compound-IV with a methylating agent
Data Source
AI summary
The present invention provides an improved process for the preparation of 8-chloro-1-phenyl-1H-benzo[b][1,4]diazepine-2,4(3H,5H)-dione (hereafter referred to as the compound (IV)), which is useful as a key intermediate for the synthesis of Clobazam (referred to as the compound (I)) 7-chloro-1-methyl-5-phenyl-1H-benzo[b][1,4]diazepine-2,4(3H,5H)-dione. The process of the present invention further involves transformation of the compound (IV) into Clobazam (I), comprising (a) reacting the compound (II) (as described herein) with monoalkyl malonate in the presence of a coupling agent to obtain the compound (III) (as described herein); followed by the cyclization using a base; (b) reacting the compound-IV (as described herein) obtained from step (a) with methylating agent. The process of the present invention involves formation of novel intermediates methyl 3-((4-chloro-2-(phenylamino)phenyl)amino)-3-oxopropanoate (IIIa) and 3-((4-chloro-2-(phenylamino)phenyl)amino)-3-oxopropanoic acid (V).